Lighthouse Announces FDA Approval To Proceed With Phase 2 Spring Trial Of LHP588
16 Nov 2023 //
PR NEWSWIRE
Lighthouse Pharmaceuticals Announces Presentation at the 2023 ASCP
24 May 2023 //
PR NEWSWIRE
Lighthouse Announces Progression of LHP588 Clinical Development Program
10 May 2023 //
PR NEWSWIRE